MENU

CRVS Corvus Pharmaceuticals Forecast, Technical & Fundamental Analysis

a provider of anticancer immuno-oncology drugs

Industry Biotechnology
CRVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
CRVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CRVS is expected to report earnings to fall 80.67% to -11 cents per share on March 06

Corvus Pharmaceuticals CRVS Stock Earnings Reports
Q4'24
Est.
$-0.12
Q3'24
Missed
by $0.49
Q2'24
Beat
by $0.05
Q1'24
Est.
$-0.12
Q4'23
Missed
by $0.02
The last earnings report on November 12 showed earnings per share of -60 cents, missing the estimate of -10 cents. With 1.37M shares outstanding, the current market capitalization sits at 474.86M.
A.I. Advisor
published General Information

General Information

a provider of anticancer immuno-oncology drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
863 Mitten Road
Phone
+1 650 900-4520
Employees
28
Web
https://www.corvuspharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA463.0226.79
+6.14%
Tesla
GME29.441.45
+5.18%
GameStop Corp
BTC.X106029.7200001731.023400
+1.66%
Bitcoin cryptocurrency
AAPL251.042.91
+1.17%
Apple
SPY606.792.58
+0.43%
SPDR® S&P 500® ETF Trust

CRVS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVS has been loosely correlated with VRDN. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if CRVS jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVS
1D Price
Change %
CRVS100%
-6.50%
VRDN - CRVS
33%
Loosely correlated
+20.67%
DNA - CRVS
32%
Poorly correlated
-0.11%
PLRX - CRVS
31%
Poorly correlated
+3.16%
KROS - CRVS
31%
Poorly correlated
+3.13%
FULC - CRVS
31%
Poorly correlated
+11.62%
More